ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Mural Oncology PLC

Mural Oncology PLC (MURA)

3.05
0.02
(0.66%)
終了 9月28日 5:00AM
3.14
0.09
(2.95%)
取引時間後: 7:57AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
3.14
買値
2.82
売値
3.37
出来高
63,194
3.00 日の範囲 3.1212
2.88 52 週間の範囲 17.00
前日終値
3.03
始値
3.08
最終取引時間
平均取引量 (3 か月)
107,488
財務取引量
US$ 194,413
VWAP
3.0764

MURA 最新ニュース

Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress

Key data readouts for the company’s late-stage, potentially registrational trials of nemvaleukin are expected in late Q1/early Q2 2025 for platinum-resistant ovarian cancer and Q2 2025 for mucosal...

Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi

WALTHAM, Mass and DUBLIN, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine...

Mural Oncology to Host First Virtual Investor Day on September 26, 2024

Company will provide clinical overview and update on late-stage clinical candidate, nemvaleukin alfa, and overview of IL-18 pipeline program Clinicians to share expert perspectives around the...

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass. and DUBLIN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine...

Mural Oncology to Present at Two Upcoming Investor Conferences

WALTHAM, Mass. and DUBLIN, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine...

Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress

Company remains well positioned to capitalize on the role of cytokines with near- and long-term potential value creation milestones, reiterates guidance on projected cash runway into Q4 2025 On...

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass. and DUBLIN, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine...

Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors

WALTHAM, Mass and DUBLIN, July 31, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.3-8.720930232563.443.483.02781663.13378301CS
4-0.11-3.384615384623.253.492.99787463.19804099CS
120.144.6666666666733.622.881074883.25853191CS
26-1.36-30.22222222224.55.11992.881581573.52751102CS
52-13.55-81.186339125216.69172.883201554.13040806CS
156-13.55-81.186339125216.69172.883201554.13040806CS
260-13.55-81.186339125216.69172.883201554.13040806CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
UXINUxin Ltd
US$ 5.145
(81.80%)
46.66M
ONCOOnconetix Inc
US$ 5.92
(76.43%)
34.66M
JFU9F Inc
US$ 2.3101
(76.34%)
2.47M
NANano Labs Ltd
US$ 1.005
(73.31%)
3.34M
CNEYCN Energy Group Inc
US$ 0.9473
(63.36%)
221.8M
ICGIntchains Group Ltd
US$ 4.77
(-43.75%)
2.86M
EDBLEdible Garden AG Inc
US$ 0.288
(-38.09%)
5.79M
DSYBig Tree Cloud Holdings Limited
US$ 2.44
(-28.24%)
416.35k
NVNOenVVeno Medical Corporation
US$ 3.255
(-27.67%)
2.36M
ADTXAditxt Inc
US$ 0.165
(-24.83%)
12.1M
NVDANVIDIA Corporation
US$ 121.40
(-2.13%)
270.95M
XPONExpion360 Inc
US$ 0.0717
(11.34%)
265.42M
CNEYCN Energy Group Inc
US$ 0.9473
(63.36%)
221.8M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.1462
(7.03%)
206.9M
SQQQProShares UltraPro Short QQQ
US$ 7.45
(1.78%)
133.61M

最近閲覧した銘柄

Delayed Upgrade Clock